AI Clinical Documentation: Difference between revisions
Restructured wiki |
Fixed doubled title |
||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
AI scribes and clinical note automation — one of the hottest digital health subsectors in 2025–2026. | AI scribes and clinical note automation — one of the hottest digital health subsectors in 2025–2026. | ||
Latest revision as of 17:29, 13 April 2026
AI scribes and clinical note automation — one of the hottest digital health subsectors in 2025–2026.
Overview[edit]
~€48 million invested across three European companies in 2025 alone (Noteless, Tandem Health, Aiomics).[1] The market sees strong potential for scaling such solutions across Europe.
Key Companies[edit]
- Noteless — €3.5M Seed, Oslo. 3,000+ clinicians, 1 in 4 GPs in Norway.
- Tandem Health — €42.6M Series A, Stockholm. 200K+ NHS staff access via Accurx.
- Dentio — $2.3M from a16z, Stockholm. Dental-specific AI documentation.
- Aiomics — €2M pre-Seed, Berlin. AI-driven healthcare documentation platform.[2]
Technology[edit]
- Speech recognition + NLP during consultations
- Real-time medical note generation
- Clinical coding extraction
- Integration with EHR systems